{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T18:23:04Z","timestamp":1792693384144,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-94761-0","type":"journal-article","created":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T04:12:17Z","timestamp":1743221537000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Identification of therapeutic targets for chronic kidney disease through Mendelian randomization analysis of druggable genes"],"prefix":"10.1038","volume":"15","author":[{"given":"Run-Sen","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Qi","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-Qi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Mei","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Yong","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Xin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cui-Wei","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,28]]},"reference":[{"issue":"1","key":"94761_CR1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.kisu.2021.11.003","volume":"12","author":"CP Kovesdy","year":"2022","unstructured":"Kovesdy, C. P. Epidemiology of chronic kidney disease: an update 2022. Kidney Int. Suppl. (2011). 12(1), 7\u201311 (2022).","journal-title":"Kidney Int. Suppl. (2011)"},{"issue":"1","key":"94761_CR2","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/ki.2013.444","volume":"85","author":"A Levin","year":"2014","unstructured":"Levin, A. & Stevens, P. E. Summary of KDIGO 2012 CKD Guideline: behind the scenes, need for guidance, and a framework for moving forward. Kidney Int. 85(1), 49\u201361 (2014).","journal-title":"Kidney Int."},{"issue":"10075","key":"94761_CR3","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/S0140-6736(16)32064-5","volume":"389","author":"AC Webster","year":"2017","unstructured":"Webster, A. C., Nagler, E. V., Morton, R. L. & Masson, P. Chronic kidney disease. Lancet ;389(10075), 1238\u20131252. (2017).","journal-title":"Lancet"},{"issue":"2","key":"94761_CR4","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa2204233","volume":"388","author":"E-K-C-G The","year":"2023","unstructured":"The, E-K-C-G. et al. Empagliflozin in patients with chronic kidney disease. N Engl. J. Med. 388(2), 117\u2013127 (2023).","journal-title":"N Engl. J. Med."},{"issue":"1","key":"94761_CR5","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/s12931-024-02848-5","volume":"25","author":"Z Liu","year":"2024","unstructured":"Liu, Z. et al. Identifying potential drug targets for idiopathic pulmonary fibrosis: a mendelian randomization study based on the druggable genes. Respir Res. 25(1), 217 (2024).","journal-title":"Respir Res."},{"key":"94761_CR6","doi-asserted-by":"crossref","first-page":"104199","DOI":"10.1016\/j.ebiom.2022.104199","volume":"83","author":"Y Chen","year":"2022","unstructured":"Chen, Y. et al. Genetic insights into therapeutic targets for aortic aneurysms: A Mendelian randomization study. EBioMedicine 83, 104199 (2022).","journal-title":"EBioMedicine"},{"key":"94761_CR7","unstructured":"Storm, C. S. et al. International Parkinson\u2019s Disease Finding genetically-supported drug targets for Parkinson\u2019s disease using Mendelian randomization of the druggable genome. Nat. Commun. 12(1), 7342. (2021)."},{"issue":"47","key":"94761_CR8","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.1093\/eurheartj\/ehad736","volume":"44","author":"SC Larsson","year":"2023","unstructured":"Larsson, S. C., Butterworth, A. S. & Burgess, S. Mendelian randomization for cardiovascular diseases: principles and applications. Eur. Heart J. 44(47), 4913\u20134924 (2023).","journal-title":"Eur. Heart J."},{"issue":"4","key":"94761_CR9","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/jrsm.1346","volume":"10","author":"J Bowden","year":"2019","unstructured":"Bowden, J. & Holmes, M. V. Meta-analysis and Mendelian randomization: A review. Res. Synth. Methods. 10(4), 486\u2013496 (2019).","journal-title":"Res. Synth. Methods"},{"key":"94761_CR10","doi-asserted-by":"crossref","unstructured":"Birney, E. Mendelian randomization. Cold Spring Harb Perspect. Med. ;12(4). (2022).","DOI":"10.1101\/cshperspect.a041302"},{"issue":"19","key":"94761_CR11","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1001\/jama.2017.17219","volume":"318","author":"CA Emdin","year":"2017","unstructured":"Emdin, C. A., Khera, A. V. &  Kathiresan, S. Mendelian randomization. JAMA ;318(19):1925\u20131926. (2017).","journal-title":"JAMA"},{"key":"94761_CR12","doi-asserted-by":"crossref","unstructured":"Finan, C. et al. The druggable genome and support for target identification and validation in drug development. Sci. Transl. Med. ;9(383). (2017).","DOI":"10.1126\/scitranslmed.aag1166"},{"issue":"9","key":"94761_CR13","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/s41588-021-00913-z","volume":"53","author":"U Vosa","year":"2021","unstructured":"Vosa, U. et al. Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression. Nat. Genet. 53(9), 1300\u20131310 (2021).","journal-title":"Nat. Genet."},{"issue":"7944","key":"94761_CR14","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","volume":"613","author":"MI Kurki","year":"2023","unstructured":"Kurki, M. I. et al. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature 613(7944), 508\u2013518 (2023).","journal-title":"Nature"},{"issue":"1","key":"94761_CR15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/gepi.22506","volume":"47","author":"A Gkatzionis","year":"2023","unstructured":"Gkatzionis, A., Burgess, S. & Newcombe, P. J. Statistical methods for cis-Mendelian randomization with two-sample summary-level data. Genet. Epidemiol. 47(1), 3\u201325 (2023).","journal-title":"Genet. Epidemiol."},{"issue":"3","key":"94761_CR16","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1177\/0962280210394459","volume":"21","author":"TM Palmer","year":"2012","unstructured":"Palmer, T. M. et al. Using multiple genetic variants as instrumental variables for modifiable risk factors. Stat. Methods Med. Res. 21(3), 223\u2013242 (2012).","journal-title":"Stat. Methods Med. Res."},{"issue":"11","key":"94761_CR17","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1002\/sim.6835","volume":"35","author":"S Burgess","year":"2016","unstructured":"Burgess, S., Dudbridge, F. & Thompson, S. G. Combining information on multiple instrumental variables in Mendelian randomization: comparison of allele score and summarized data methods. Stat. Med. 35(11), 1880\u20131906 (2016).","journal-title":"Stat. Med."},{"issue":"R2","key":"94761_CR18","doi-asserted-by":"crossref","first-page":"R195","DOI":"10.1093\/hmg\/ddy163","volume":"27","author":"G Hemani","year":"2018","unstructured":"Hemani, G., Bowden, J. & Davey Smith, G. Evaluating the potential role of pleiotropy in Mendelian randomization studies. Hum. Mol. Genet. 27(R2), R195\u2013R208 (2018).","journal-title":"Hum. Mol. Genet."},{"issue":"5","key":"94761_CR19","doi-asserted-by":"crossref","first-page":"e1004383","DOI":"10.1371\/journal.pgen.1004383","volume":"10","author":"C Giambartolomei","year":"2014","unstructured":"Giambartolomei, C. et al. Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLoS Genet. 10(5), e1004383 (2014).","journal-title":"PLoS Genet."},{"issue":"1","key":"94761_CR20","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Ashburner, M. et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 25(1), 25\u201329 (2000).","journal-title":"Nat. Genet."},{"key":"94761_CR21","unstructured":"Gene Ontology, C. et al. The Gene Ontology knowledgebase in 2023. Genetics. 224(1). (2023)."},{"issue":"D1","key":"94761_CR22","doi-asserted-by":"crossref","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. & Ishiguro-Watanabe, M. KEGG: biological systems database as a model of the real world. Nucleic Acids Res. 53(D1), D672\u2013D7 (2025).","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"94761_CR23","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 28(11), 1947\u20131951 (2019).","journal-title":"Protein Sci."},{"issue":"1","key":"94761_CR24","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28(1), 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"issue":"19","key":"94761_CR25","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1093\/bioinformatics\/btu393","volume":"30","author":"Z Gu","year":"2014","unstructured":"Gu, Z., Gu, L., Eils, R., Schlesner, M. & Brors, B. circlize Implements and enhances circular visualization in R. Bioinformatics 30(19), 2811\u20132812 (2014).","journal-title":"Bioinformatics"},{"key":"94761_CR26","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0091-679X(10)95007-3","volume":"95","author":"LM Miller","year":"2010","unstructured":"Miller, L. M. et al. Methods in tubulin proteomics. Methods Cell. Biol. 95, 105\u2013126 (2010).","journal-title":"Methods Cell. Biol."},{"key":"94761_CR27","doi-asserted-by":"crossref","unstructured":"Goodson, H. V. & Jonasson, E. M. Microtubules and microtubule-associated proteins. Cold Spring Harb. Perspect. Biol. ;10(6). (2018).","DOI":"10.1101\/cshperspect.a022608"},{"key":"94761_CR28","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1146\/annurev-cellbio-100616-060615","volume":"33","author":"J Wu","year":"2017","unstructured":"Wu, J. & Akhmanova, A. Microtubule-organizing centers. Annu. Rev. Cell. Dev. Biol. 33, 51\u201375 (2017).","journal-title":"Annu. Rev. Cell. Dev. Biol."},{"key":"94761_CR29","doi-asserted-by":"crossref","first-page":"1365655","DOI":"10.3389\/fmolb.2024.1365655","volume":"11","author":"Z Zhu","year":"2024","unstructured":"Zhu, Z. et al. TUBB, a robust biomarker with satisfying abilities in diagnosis, prognosis, and immune regulation via a comprehensive pan-cancer analysis. Front. Mol. Biosci. 11, 1365655 (2024).","journal-title":"Front. Mol. Biosci."},{"key":"94761_CR30","doi-asserted-by":"crossref","unstructured":"Wordeman, L. & Vicente, J. J. Microtubule targeting agents in disease: classic drugs, novel roles. Cancers. 13(22). (2021).","DOI":"10.3390\/cancers13225650"},{"issue":"5124","key":"94761_CR31","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1126\/science.8102497","volume":"261","author":"TJ Mitchison","year":"1993","unstructured":"Mitchison, T. J. Localization of an exchangeable GTP binding site at the plus end of microtubules. Science 261(5124), 1044\u20131047 (1993).","journal-title":"Science"},{"issue":"28","key":"94761_CR32","doi-asserted-by":"crossref","first-page":"17141","DOI":"10.1016\/S0021-9258(17)44880-0","volume":"265","author":"RL Bai","year":"1990","unstructured":"Bai, R. L., Pettit, G. R. & Hamel, E. Binding of dolastatin 10 to tubulin at a distinct site for peptide antimitotic agents near the exchangeable nucleotide and vinca alkaloid sites. J. Biol. Chem. 265(28), 17141\u201317149 (1990).","journal-title":"J. Biol. Chem."},{"issue":"12","key":"94761_CR33","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/0006-2952(90)90613-P","volume":"39","author":"R Bai","year":"1990","unstructured":"Bai, R., Pettit, G. R. & Hamel, E. Dolastatin 10, a powerful cytostatic peptide derived from a marine animal. Inhibition of tubulin polymerization mediated through the vinca alkaloid binding domain. Biochem. Pharmacol. 39(12), 1941\u20131949 (1990).","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"94761_CR34","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0163-7258(92)90028-X","volume":"55","author":"E Hamel","year":"1992","unstructured":"Hamel, E. Natural products which interact with tubulin in the vinca domain: maytansine, rhizoxin, phomopsin A, dolastatins 10 and 15 and halichondrin B. Pharmacol. Ther. 55(1), 31\u201351 (1992).","journal-title":"Pharmacol. Ther."},{"issue":"6979","key":"94761_CR35","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/nature02393","volume":"428","author":"RB Ravelli","year":"2004","unstructured":"Ravelli, R. B. et al. Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain. Nature 428(6979), 198\u2013202 (2004).","journal-title":"Nature"},{"issue":"6663","key":"94761_CR36","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/34465","volume":"391","author":"E Nogales","year":"1998","unstructured":"Nogales, E., Wolf, S. G. & Downing, K. H. Structure of the alpha beta tubulin dimer by electron crystallography. Nature 391(6663), 199\u2013203 (1998).","journal-title":"Nature"},{"issue":"3","key":"94761_CR37","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0304-4165(87)90206-6","volume":"926","author":"M Takahashi","year":"1987","unstructured":"Takahashi, M. et al. Rhizoxin binding to tubulin at the maytansine-binding site. Biochim. Biophys. Acta. 926(3), 215\u2013223 (1987).","journal-title":"Biochim. Biophys. Acta"},{"issue":"38","key":"94761_CR38","doi-asserted-by":"crossref","first-page":"13817","DOI":"10.1073\/pnas.1408124111","volume":"111","author":"AE Prota","year":"2014","unstructured":"Prota, A. E. et al. A new tubulin-binding site and pharmacophore for microtubule-destabilizing anticancer drugs. Proc. Natl. Acad. Sci. U S A. 111(38), 13817\u201313821 (2014).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"6","key":"94761_CR39","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1002\/anie.201307749","volume":"53","author":"AE Prota","year":"2014","unstructured":"Prota, A. E. et al. Structural basis of microtubule stabilization by laulimalide and peloruside A. Angew Chem. Int. Ed. Engl. 53(6), 1621\u20131625 (2014).","journal-title":"Angew Chem. Int. Ed. Engl."},{"issue":"12","key":"94761_CR40","first-page":"3356","volume":"62","author":"KA Hood","year":"2002","unstructured":"Hood, K. A. et al. Peloruside A, a novel antimitotic agent with paclitaxel-like microtubule- stabilizing activity. Cancer Res. 62(12), 3356\u20133360 (2002).","journal-title":"Cancer Res."},{"key":"94761_CR41","doi-asserted-by":"crossref","unstructured":"Matthew, S. et al. Gatorbulin-1, a distinct cyclodepsipeptide chemotype, targets a seventh tubulin pharmacological site. Proc. Natl. Acad. Sci. U S A ;118(9). (2021).","DOI":"10.1073\/pnas.2021847118"},{"key":"94761_CR42","doi-asserted-by":"crossref","unstructured":"Yang, J. et al. Cevipabulin-tubulin complex reveals a novel agent binding site on alpha-tubulin with tubulin degradation effect. Sci. Adv. ;7(21). (2021).","DOI":"10.1126\/sciadv.abg4168"},{"issue":"4","key":"94761_CR43","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nrc1317","volume":"4","author":"MA Jordan","year":"2004","unstructured":"Jordan, M. A. & Wilson, L. Microtubules as a target for anticancer drugs. Nat. Rev. Cancer. 4(4), 253\u2013265 (2004).","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"94761_CR44","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3892\/ol.2021.12966","volume":"22","author":"YY Lan","year":"2021","unstructured":"Lan, Y. Y. et al. Role of JNK activation in paclitaxel-induced apoptosis in human head and neck squamous cell carcinoma. Oncol. Lett. 22(4), 705 (2021).","journal-title":"Oncol. Lett."},{"issue":"5","key":"94761_CR45","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1517\/17460441.3.5.501","volume":"3","author":"B Fennell","year":"2008","unstructured":"Fennell, B. et al. Microtubules as antiparasitic drug targets. Expert Opin. Drug Discov. 3(5), 501\u2013518 (2008).","journal-title":"Expert Opin. Drug Discov"},{"key":"94761_CR46","doi-asserted-by":"crossref","first-page":"27775","DOI":"10.1038\/srep27775","volume":"6","author":"SJ Han","year":"2016","unstructured":"Han, S. J., Kim, J. H., Kim, J. I. & Park, K. M. Inhibition of microtubule dynamics impedes repair of kidney ischemia\/reperfusion injury and increases fibrosis. Sci. Rep. 6, 27775 (2016).","journal-title":"Sci. Rep."},{"issue":"11","key":"94761_CR47","doi-asserted-by":"crossref","first-page":"e111364","DOI":"10.1371\/journal.pone.0111364","volume":"9","author":"J Yang","year":"2014","unstructured":"Yang, J. et al. Identification of potential serum proteomic biomarkers for clear cell renal cell carcinoma. PLoS One. 9(11), e111364 (2014).","journal-title":"PLoS One"},{"key":"94761_CR48","doi-asserted-by":"crossref","unstructured":"Wang, Y., Hu, L., Zhou, D., Chen, X. & Zhou, L. Association of urinary biomarkers of renal tubular injury with cognitive dysfunction in older patients with chronic kidney disease: a cross-sectional observational study. Brain Sci. 13(4). (2023).","DOI":"10.3390\/brainsci13040551"},{"issue":"1","key":"94761_CR49","first-page":"45","volume":"1","author":"J Zhang","year":"2024","unstructured":"Zhang, J. et al. Promotion of inflammation, apoptosis, and inhibition of autophagy by overexpression of lncRNA SNHG12 in acute kidney injury. Iran. J. Kidney Dis. 1(1), 45\u201355 (2024).","journal-title":"Iran. J. Kidney Dis."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94761-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94761-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94761-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T04:13:51Z","timestamp":1743221631000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94761-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,28]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["94761"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-94761-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5088380\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,28]]},"assertion":[{"value":"14 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol received approval from the Medical Ethics Committee of the Affiliated Hospital of Guangdong Medical University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10779"}}